Pattern of Use of Biosimilar and Originator Somatropin in Italy: A Population-Based Multiple Databases Study During the Years 2009–2014

PURPOSE: Somatropin [recombinant growth hormone (rGH)] is approved in children and adults for several conditions involving growth disturbances and the corresponding biosimilar is available in Italy since 2006. No population-based data are available on the pattern of rGH use in Italian clinical pract...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Front Endocrinol (Lausanne)
Autores principales: Marcianò, Ilaria, Ingrasciotta, Ylenia, Giorgianni, Francesco, Ientile, Valentina, Chinellato, Alessandro, Tari, Daniele Ugo, Gini, Rosa, Cannavò, Salvatore, Pastorello, Maurizio, Scondotto, Salvatore, Cananzi, Pasquale, Traversa, Giuseppe, Trotta, Francesco, Belleudi, Valeria, Addis, Antonio, Trifirò, Gianluca
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Media S.A. 2018
Materias:
Endocrinology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5859012/
https://ncbi.nlm.nih.gov/pubmed/29593655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2018.00095
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares